Preventation of Cytomegalovirus Reactivation
1 clinical trials · Condition
◉ Watch Preventation of Cytomegalovirus Reactivation
| Record | Firm | Date |
|---|---|---|
| Evaluate Tolerability and Safety of BD03 for Prevention of CMV and BKV Reactivation in Kidney Transplant Recipient (NCT03576014) | SL VAXiGEN | 2018-04-27 |
Track Preventation of Cytomegalovirus Reactivation automatically
Every clearance here is in the API, with alerts when new ones post.